GlaxoSmithKline (LON:GSK) Given a GBX 1600 Price Target at UBS

Glg Llc who had been investing in Comerica Inc for a number of months, seems to be less bullish one the $16.59B market cap company. They expect $2.23 earnings per share, up 12.06% or $0.24 from last year's $1.99 per share. The investment managers in our database now own: 1.13 million shares, up from 1.04 million shares in 2017Q3.

Hbk Sorce Advisory Llc, which manages about $1.80 billion and $847.68 million US Long portfolio, upped its stake in Schwab Strategic Tr (SCHX) by 61,486 shares to 2.64 million shares, valued at $168.17 million in 2017Q4, according to the filing. Wealthcare Advisory Partners LLC increased its stake in shares of GlaxoSmithKline by 1,982.8% in the third quarter. They expect $0.68 earnings per share, up 3.03% or $0.02 from last year's $0.66 per share. If $0.71 is reported, GSK's profit will reach $1.69B for 14.29 P/E. After $0.27 actual EPS reported by Allegheny Technologies Incorporated for the previous quarter, Wall Street now forecasts -14.81% negative EPS growth.

One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and five have issued a buy rating to the stock. 7 are the (NYSE:GSK)'s analyst reports since October 26, 2017 according to StockzIntelligence Inc. UBS maintained it with "Neutral" rating and $5.25 target in Tuesday, September 8 report. GlaxoSmithKline plc (NYSE:GSK) has declined 10.07% since April 14, 2017 and is downtrending. The stock of GlaxoSmithKline plc (NYSE:GSK) earned "Underweight" rating by Morgan Stanley on Friday, September 8. Jefferies upgraded GlaxoSmithKline plc (NYSE:GSK) on Thursday, July 14 to "Buy" rating. The firm earned "Hold" rating on Wednesday, February 14 by Cowen & Co. The company was downgraded on Wednesday, July 5 by Citigroup. The firm has "Buy" rating given on Wednesday, September 21 by Dundee Securities. On Thursday, October 26 the stock rating was maintained by SunTrust with "Buy". The stock has an average rating of "Hold" and a consensus price target of GBX 1,554.32 ($21.97).

Since February 15, 2018, it had 0 buys, and 1 sale for $1.07 million activity. Therefore 73% are positive. Brown & Brown had 52 analyst reports since August 24, 2015 according to SRatingsIntel. The stock of Praxair, Inc. On Monday, December 11 the firm has "Hold" rating by Cowen & Co given. Compass Point maintained Brown & Brown, Inc. Oppenheimer initiated the shares of ENPH in report on Wednesday, September 9 with "Outperform" rating. The firm has "Buy" rating by Investec given on Thursday, October 20. (NYSE:BRO) has "Underperform" rating given on Friday, November 4 by BMO Capital Markets. Deutsche Bank maintained it with "Hold" rating and GBX 1540 target in Thursday, April 28 report. The rating was upgraded by BNP Paribas on Wednesday, April 5 to "Neutral". The stock has "Hold" rating by Shore Capital on Friday, June 2. Nomura has "Reduce" rating and $72.5 target. (NASDAQ:LPLA) has "Neutral" rating given on Tuesday, January 10 by Goldman Sachs. Its up 2.37, from 0.8 in 2017Q3. It improved, as 46 investors sold ADI shares while 224 reduced holdings. 30 funds opened positions while 73 raised stakes. It also reduced its holding in Spdr S&P 500 Etf Tr (SPY) by 3.51M shares in the quarter, leaving it with 250,000 shares, and cut its stake in Colgate Palmolive Co (NYSE:CL). (NASDAQ:ADI). Gemmer Asset Mngmt holds 0.01% of its portfolio in Analog Devices, Inc. (NYSE:BRO). Royal Natl Bank Of Canada has 0.01% invested in Brown & Brown, Inc. Savings Bank Of America De reported 0% stake. Point72 Asset Management L.P. now owns 604,419 shares of the pharmaceutical company's stock valued at $24,539,000 after buying an additional 504,419 shares during the period. The New York-based Three Corner Global Investors Lp has invested 10.4% in the stock. Mraz Amerine & Associates Inc., a California-based fund reported 58,472 shares. Covington Cap reported 180 shares. Amussen Hunsaker Associates LLC acquired a new position in shares of GlaxoSmithKline in the fourth quarter worth $141,000. Tarbox Family Office has invested 0% in Genworth Financial, Inc. Credit Suisse Ag reported 563,911 shares or 0.05% of all its holdings.

Related news: